First Priority, Inc. is recalling approximately 84,554 bottles of Phenylbutazone (1 gram) boluses used as a non-steroidal anti-inflammatory drug for horses. The recall was initiated because the product was manufactured using sodium alginate instead of the required alginic acid. This formulation error may affect the drug's performance or stability. No incidents or injuries have been reported to date.
The use of an incorrect inactive ingredient (sodium alginate instead of alginic acid) could potentially alter how the medication is absorbed or how the bolus dissolves, which may lead to reduced effectiveness in treating inflammation in horses.
You have 2 options:
Distributed under multiple labels: Priority Care, Vedco, Henry Schein, MWI, and Covetrus.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response